EN DE

Arkema S.A (AKE) Fair Value & Analysis

Basic Materials · FR · Market cap €4.3B

AS Arkema S.A AKE · PA
Price€61.45
Fair Value€80.48
Upside+31.0%
Quality49/100
Watch Arkema S.A for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 0.5% net margin
Moderate debt · generates free cash flow
6.42% dividend yield
Mixed vs. peers (6/15)
Narrow moat 27/100
Evidence: High Range €54.96 – €80.48 Share as image

Fair value as of: Jul 15, 2026

From 24 valuation models · updated 25 days ago

Fair value updated Jul 15, 2026, revised from €40.21 to €80.48 (+100.1%) since Jul 14, 2026. Share price +12.4% over the past month.

Below-average quality, screening 31% undervalued on our models.

What matters now

  • Solid quality (49/100) at a price below fair value, the discount is the argument here, not the business quality.
  • Our model range runs from €54.96 (bear) to €80.48 (bull), base €80.48. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 49/100 (below-average quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

€108.35 €45.66 Fair Value €80.48 Jun 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.

How to read this chart

60‑month range €45.66 – €108.35 · fair‑value band €54.96 – €80.48 · the €61.45 price screens below the €80.48 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 15, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Arkema S.A (AKE) currently trades at €61.45, while our model-based Fair Value estimate is €80.48, implying the stock looks roughly 31.0% undervalued today. The Quality Score stands at 49/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Arkema S.A generated revenue of €8.9B at a net margin of 0.5%. Revenue declined 8.4% year over year. It earns a return on equity of 0.5%. Net debt stands at €3.2B. Fundamentals as of Jul 15, 2026

Our scenario range runs from €54.96 (bear case) to €80.48 (bull case); at €61.45, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 35% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at 31%, AKE screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF €26.99 €40.90 €64.09 80
Residual Income €54.15 €50.89 €36.52 76
Rev-Margin DCF €27.80 €49.75 €76.68 74
All 24 models by family
DCF Models
FCF DCF €25.50 €39.90 €65.90 38
Owner Earnings €15.42 €26.44 €46.35 31
5Y Revenue Exit €27.80 €49.01 €79.48 39
5Y EBITDA Exit €64.72 €112.01 €173.65 41
5Y P/E Exit €4.82 €9.79 €15.79 38
10Y Revenue Exit €25.20 €43.32 €64.22 36
10Y EBITDA Exit €48.72 €84.07 €125.18 37
10Y P/E Exit €12.70 €17.96 €23.00 35
Earnings-Based
Graham-Dodd €5.66 €9.85 €12.07 54
EPV €20.94 €27.01 €32.25 59
Dividend Discount
Gordon GGM €31.57 €39.77 €48.02 70
DDM Multi-Stage €31.57 €42.09 €54.44 61
Multiples
P/E Multiple €10.61 €14.15 €17.69 63
P/S Multiple €10.61 €14.15 €17.69 58
P/B Multiple €10.61 €14.15 €17.69 55
EV/EBIT €40.78 €60.20 €79.63 53
EV/EBITDA €106.48 €147.81 €189.13 54
EV/Revenue €33.01 €54.65 €76.30 43
Asset-Based
NCAV (Graham) €39.93 €53.50 €79.85 50
Growth DCF
Growth DCF €26.99 €40.90 €64.09 80
Rev-Margin DCF €27.80 €49.75 €76.68 74
Economic Profit
Residual Income €54.15 €50.89 €36.52 76
ROIC Compounder €20.94 €27.01 €32.25 72
Growth Earnings
Growth-Adj P/E €7.56 €10.80 €14.04 68

Widest divergence: Asset-Based (€53.50) versus Earnings-Based (€9.85). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) €8.9B
Revenue growth (YoY) -8.4%
Net margin 0.5%
Return on equity 0.5%
Free cash flow €337M FY2025
P/E ratio 247.8
More key figures
Operating margin 3.4%
EPS (TTM) €0.2300
Dividend yield 6.4%
EPS growth (YoY) -84.8%
Net debt €3.2B FY2025

Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 49/100

Of which business quality 48 · Market factors (momentum, volatility) 55

Profitability 23
Margins and returns on capital today
Quality Growth 32
Are margins and returns improving?
Cashflow 44
Earnings quality: real cash, not paper profit
Fin. Strength 49
Balance sheet, leverage, solvency risk
Investment 88
Disciplined investing over empire-building
Low Volatility 62
Calm price path (market factor)
Momentum 44
Price trend over the last 3–12 months (market factor)
52W Momentum 64
Distance to the 52-week high (market factor)
Net Issuance 73
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates.

Full company description

Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides solutions for construction, renovation of buildings, and DIY; high performance adhesives for durable goods, and adhesive solutions for packaging and non-woven; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. It also offers high performance polymers, such as specialty polyamides, PVDF, polyimides, fluorospecialties, and PEKK; and performance additives comprising interface agents combining specialty surfactants, molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide. In addition, the company provides lightweighting, new energies, access to water, bio-based products, and recycling solutions for automotive and transportation sectors, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition and water treatment. Further, it offers coating solutions, including EU/US acrylics and coating resins; coating additives, such as sartomer photocure resins, and coatex rheology additives and specialties; decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbent, water treatment and oil and gas extraction, and 3D printing and electronics markets. Additionally, the company provides fluorogases and asia acrylics; and industrial intermediate chemicals for construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Puteaux, France.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Arkema S.A reported revenue of €9.1B in FY2025 versus €9.5B in FY2021, a compound −1.2%/yr. Reported net income was €63.0M in FY2025, compounding −53.2%/yr from FY2021.

Growth Quality 53/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
€9.1B
Latest YoY
−5.0%
Avg. growth/yr (3Y)
−7.7%
Avg. growth/yr (5Y)
+2.8%
Avg. growth/yr (24Y)
+1.8%
Revenue −1.2%/yr
FY21 €9.5B
FY22 €11.6B
FY23 €9.5B
FY24 €9.5B
FY25 €9.1B
Net income −53.2%/yr
FY21 €1.3B
FY22 €965M
FY23 €402M
FY24 €354M
FY25 €63.0M

Watch AKE: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Arkema S.A Fair Value". https://www.fairvalue-calculator.com/stock/AKE

Earlier news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Specialty Chemicals · 676 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 49 · Below median
Fair Value upside +31% · Top 25%
Return on equity (TTM) 1% · Below median
Return on assets 2% · Below median
Net margin (TTM) 0% · Below median
Operating margin (TTM) 3% · Below median
Revenue growth -8% · Bottom 25%
Dividend yield (TTM) 6.4% · Top 25%
Debt / equity 0.58× · Higher than 75% of peers

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 247.8× · Pricier than 75% of peers
P/B 0.83× · Cheaper than median
P/S (TTM) 0.56× · Cheaper than median
P/FCF 14.8× · Pricier than 75% of peers
EV/EBITDA 5.7× · Cheaper than 75% of peers
PEG 0.47× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 75 · sector 0
FUTURE 0 · sector 19
PAST 2 · sector 23
HEALTH 71 · sector 95
DIVIDEND 100 · sector 25

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare Arkema S.A with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Arkema S.A (AKE) overvalued or undervalued?
As of Jul 15, 2026, our model estimates a fair value of €80.48 versus a price of €61.45, about +31% (undervalued).
What is the fair value of AKE?
Our model-based fair value for Arkema S.A is €80.48 (as of Jul 15, 2026), built from audited fundamentals. The current price is €61.45.
What is the quality score of AKE?
Arkema S.A has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Arkema S.A (AKE)?
Arkema S.A reported trailing-twelve-month revenue of about €8.9B (latest available figure, as of Jul 15, 2026).
What is the net profit margin of AKE?
The net profit margin of Arkema S.A is about 0.5%, meaning it keeps roughly 0.5% of revenue as net income. Based on the latest reported figures.
Does Arkema S.A pay a dividend?
Arkema S.A currently shows a dividend yield of about 5.94% relative to its recent price (as of Jul 15, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Arkema S.A and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.